Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3,435 JPY | +1.15% | +3.03% | +2.57% |
Business Summary
- manufacturing of food products (81.5% of net sales): infantile nutrition products, confectionery, dairy products, beverages, energetic products, frozen products, etc.;
- manufacturing of pharmaceutical products (18.5%): prescription drugs and OTC products.
Number of employees: 17,290
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Food
81.4
%
| 825,451 | 81.5 % | 864,894 | 81.4 % | +4.78% |
Pharmaceuticals
18.6
%
| 187,641 | 18.5 % | 197,262 | 18.6 % | +5.13% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
88.5
%
| 1,013,092 | 100.0 % | 939,725 | 88.5 % | -7.24% |
Asia (Excluding China)
3.4
%
| 0 | 0.0 % | 35,848 | 3.4 % | - |
North America
3.0
%
| - | - | 32,000 | 3.0 % | - |
China
2.3
%
| - | - | 24,104 | 2.3 % | - |
Europe
1.4
%
| - | - | 15,250 | 1.4 % | - |
Others
1.4
%
| 0 | 0.0 % | 15,228 | 1.4 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kazuo Kawamura
CEO | Chief Executive Officer | 70 | 12-05-31 |
Director of Finance/CFO | 69 | 15-05-31 | |
Chief Operating Officer | 66 | 18-06-27 | |
Chief Operating Officer | 69 | 14-05-31 | |
Jun Furuta
BRD | Director/Board Member | 66 | 14-05-31 |
Yuhei Matsumoto
HRO | Human Resources Officer | - | - |
Hiroyuki Tanaka
AUD | Comptroller/Controller/Auditor | 69 | 17-06-28 |
Mineo Matsuzumi
AUD | Comptroller/Controller/Auditor | 69 | 17-06-28 |
Hayato Shimada
AUD | Comptroller/Controller/Auditor | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jun Furuta
BRD | Director/Board Member | 66 | 14-05-31 |
Director/Board Member | 77 | 16-05-31 | |
Tohru Murayama
BRD | Director/Board Member | 69 | 16-05-31 |
Kazuo Kawamura
CEO | Chief Executive Officer | 70 | 12-05-31 |
Chief Operating Officer | 69 | 14-05-31 | |
Director of Finance/CFO | 69 | 15-05-31 | |
Chief Operating Officer | 66 | 18-06-27 | |
Mariko Matsumura
BRD | Director/Board Member | 64 | 18-06-27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 293,459,000 | 250,866,129 ( 85.49 %) | 14,351,604 ( 4.890 %) | 85.49 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
MEIJI HOLDINGS CO LTD 4.89% | 14,350,400 | 4.89% | 321,057,481 $ |
ORIENTAL LAND CO., LTD. 0.16% | 2,875,000 | 0.16% | 92,113,218 $ |
KIKKOMAN CORPORATION 0.64% | 6,192,000 | 0.64% | 80,557,982 $ |
AUSTASIA GROUP LTD. 22.19% | 155,451,785 | 22.19% | 25,026,183 $ |
YAKULT HONSHA CO.,LTD. 0.31% | 1,062,400 | 0.31% | 21,894,513 $ |
1,209,900 | 0.24% | 19,622,049 $ | |
1,191,987 | 7.78% | 16,366,244 $ | |
TOYO SUISAN KAISHA, LTD. 0.21% | 232,000 | 0.21% | 14,524,432 $ |
1,045,220 | 0.34% | 14,499,585 $ | |
SHOEI FOODS CORPORATION 2.50% | 428,000 | 2.50% | 13,305,625 $ |
Company contact information
Group companies
Name | Category and Sector |
---|---|
Medreich Ltd.
Medreich Ltd. Pharmaceuticals: MajorHealth Technology Medreich Ltd. manufactures and distributes pharmaceutical products. It also offers research and development, documentation services, and insights in the pharmaceutical domain. The firm is involved in manufacturing of formulations for multinationals like GlaxoSmithKline, Pfizer, Sanofi Aventis, Wyeth, Adcock Ingram, Mylan, and Actavis. The company was founded in 1976 and is headquartered in Bangalore, India. |
Pharmaceuticals: Major
|
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.57% | 6.13B | |
-3.29% | 268B | |
-7.26% | 90.35B | |
+0.35% | 45.11B | |
+0.58% | 40.42B | |
+6.06% | 39B | |
-0.85% | 37.75B | |
-14.54% | 30.97B | |
-8.40% | 28.41B | |
-9.38% | 22.66B |
- Stock Market
- Equities
- 2269 Stock
- Company Meiji Holdings Co Ltd